Cargando…
造血干细胞移植后复发急性B淋巴细胞白血病CD19 CAR-T细胞治疗后的维持治疗
OBJECTIVE: This study aimed to evaluate the maintenance therapy following an anti-CD19-CAR T-cell therapy for a B-cell acute lymphoblastic leukemia (ALL) patient who relapsed after allogeneic hematopoietic cell transplantation (allo-HSCT) and investigate the effect of donor stem cells and donor T ly...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7378295/ https://www.ncbi.nlm.nih.gov/pubmed/32654464 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2020.06.011 |
Ejemplares similares
-
CART序贯二次异基因造血干细胞移植治疗移植后复发急性B淋巴细胞白血病41例临床分析
Publicado: (2021) -
酪氨酸激酶抑制剂联合化疗后行异基因造血干细胞移植治疗Ph(+)急性淋巴细胞白血病与异基因造血干细胞移植治疗Ph(−)急性淋巴细胞白血病的疗效比较
Publicado: (2015) -
CAR-T细胞桥接异基因造血干细胞移植治疗复发/难治急性B淋巴细胞白血病的临床分析
Publicado: (2020) -
异基因造血干细胞移植治疗T淋巴母细胞白血病/淋巴瘤的疗效及预后因素
Publicado: (2023) -
嵌合抗原受体T细胞治疗儿童急性B淋巴细胞白血病异基因造血干细胞移植后复发一例报告并文献复习
Publicado: (2016)